Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Pancreatic Cancer | Research

Establishment and validation of a nomogram based on coagulation parameters to predict the prognosis of pancreatic cancer

Authors: Peng Yunpeng, Yin Lingdi, Zhu Xiaole, Huang Dongya, Hu Le, Lu Zipeng, Zhang Kai, Hou Chaoqun, Miao Yi, Guo Feng, Li Qiang

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Background

In recent years, multiple coagulation and fibrinolysis (CF) indexes have been reported to be significantly related to the progression and prognosis of some cancers.

Objective

The purpose of this study was to comprehensively analyze the value of CF parameters in prognosis prediction of pancreatic cancer (PC).

Methods

The preoperative coagulation related data, clinicopathological information, and survival data of patients with pancreatic tumor were collected retrospectively. Mann Whitney U test, Kaplan-Meier analysis, and Cox proportional hazards regression model were applied to analyze the differences of coagulation indexes between benign and malignant tumors, as well as the roles of these indexes in PC prognosis prediction.

Results

Compared with benign tumors, the preoperative levels of some traditional coagulation and fibrinolysis (TCF) indexes (such as TT, Fibrinogen, APTT, and D-dimer) were abnormally increased or decreased in patients with pancreatic cancer, as well as Thromboelastography (TEG) parameters (such as R, K, α Angle, MA, and CI). Kaplan Meier survival analysis based on resectable PC patients showed that the overall survival (OS) of patients with elevated α angle, MA, CI, PT, D-dimer, or decreased PDW was markedly shorter than other patients; moreover, patients with lower CI or PT have longer disease-free survival. Further univariate and multivariate analysis revealed that PT, D-dimer, PDW, vascular invasion (VI), and tumor size (TS) were independent risk factors for poor prognosis of PC. According to the results of modeling group and validation group, the nomogram model based on independent risk factors could effectively predict the postoperative survival of PC patients.

Conclusion

Many abnormal CF parameters were remarkably correlated with PC prognosis, including α Angle, MA, CI, PT, D-dimer, and PDW. Furthermore, only PT, D-dimer, and PDW were independent prognostic indicators for poor prognosis of PC, and the prognosis prediction model based on these indicators was an effective tool to predict the postoperative survival of PC.
Appendix
Available only for authorised users
Literature
1.
2.
5.
go back to reference Aziz MH, Sideras K, Aziz NA, et al. The systemic-immune-inflammation index independently predicts survival and recurrence in Resectable Pancreatic Cancer and its Prognostic Value depends on bilirubin levels: a retrospective Multicenter Cohort Study. Ann Surg. 2019;270(1):139–46.PubMedCrossRef Aziz MH, Sideras K, Aziz NA, et al. The systemic-immune-inflammation index independently predicts survival and recurrence in Resectable Pancreatic Cancer and its Prognostic Value depends on bilirubin levels: a retrospective Multicenter Cohort Study. Ann Surg. 2019;270(1):139–46.PubMedCrossRef
6.
go back to reference Orhan A, Vogelsang RP, Andersen MB, et al. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis. Eur J Cancer. 2020;132:71–84.PubMedCrossRef Orhan A, Vogelsang RP, Andersen MB, et al. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis. Eur J Cancer. 2020;132:71–84.PubMedCrossRef
7.
go back to reference Sun Q, Ye Z, Qin Y, et al. Oncogenic function of TRIM2 in pancreatic cancer by activating ROS-related NRF2/ITGB7/FAK axis. Oncogene. 2020;39(42):6572–88.PubMedCrossRef Sun Q, Ye Z, Qin Y, et al. Oncogenic function of TRIM2 in pancreatic cancer by activating ROS-related NRF2/ITGB7/FAK axis. Oncogene. 2020;39(42):6572–88.PubMedCrossRef
8.
go back to reference Guo X, Li K, Jiang W, et al. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner. Mol Cancer. 2020;19(1):91.PubMedPubMedCentralCrossRef Guo X, Li K, Jiang W, et al. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner. Mol Cancer. 2020;19(1):91.PubMedPubMedCentralCrossRef
9.
go back to reference Yan H, Qiu W, Koehne de Gonzalez AK, et al. HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. Cancer Lett. 2019;442:333–40.PubMedCrossRef Yan H, Qiu W, Koehne de Gonzalez AK, et al. HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. Cancer Lett. 2019;442:333–40.PubMedCrossRef
10.
go back to reference Wang H, Gao J, Bai M, et al. The pretreatment platelet and plasma fibrinogen level correlate with tumor progression and metastasis in patients with pancreatic cancer. Platelets. 2014;25(5):382–7.PubMedCrossRef Wang H, Gao J, Bai M, et al. The pretreatment platelet and plasma fibrinogen level correlate with tumor progression and metastasis in patients with pancreatic cancer. Platelets. 2014;25(5):382–7.PubMedCrossRef
11.
go back to reference Guo Q, Zhang B, Dong X, et al. Elevated levels of plasma fibrinogen in patients with pancreatic cancer: possible role of a distant metastasis predictor. Pancreas. 2009;38(3):e75–79.PubMedCrossRef Guo Q, Zhang B, Dong X, et al. Elevated levels of plasma fibrinogen in patients with pancreatic cancer: possible role of a distant metastasis predictor. Pancreas. 2009;38(3):e75–79.PubMedCrossRef
12.
go back to reference Kurahara H, Maemura K, Mataki Y, et al. Prognostication by inflammation-based score in patients with locally advanced pancreatic cancer treated with chemoradiotherapy. Pancreatology. 2015;15(6):688–93.PubMedCrossRef Kurahara H, Maemura K, Mataki Y, et al. Prognostication by inflammation-based score in patients with locally advanced pancreatic cancer treated with chemoradiotherapy. Pancreatology. 2015;15(6):688–93.PubMedCrossRef
13.
go back to reference Chung KH, Lee JC, Lee J, et al. Serum fibrinogen as a diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma. Pancreatology. 2020;20(7):1465–71.PubMedCrossRef Chung KH, Lee JC, Lee J, et al. Serum fibrinogen as a diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma. Pancreatology. 2020;20(7):1465–71.PubMedCrossRef
14.
go back to reference Mattila N, Seppanen H, Mustonen H, Przybyla B, Haglund C, Lassila R. Preoperative Biomarker Panel, including fibrinogen and FVIII, improves diagnostic accuracy for pancreatic ductal adenocarcinoma. Clin Appl Thromb Hemost. 2018;24(8):1267–75.PubMedPubMedCentralCrossRef Mattila N, Seppanen H, Mustonen H, Przybyla B, Haglund C, Lassila R. Preoperative Biomarker Panel, including fibrinogen and FVIII, improves diagnostic accuracy for pancreatic ductal adenocarcinoma. Clin Appl Thromb Hemost. 2018;24(8):1267–75.PubMedPubMedCentralCrossRef
15.
go back to reference Stender MT, Larsen AC, Sall M, Thorlacius-Ussing O. D-Dimer predicts prognosis and non-resectability in patients with pancreatic cancer: a prospective cohort study. Blood Coagul Fibrinolysis. 2016;27(5):597–601.PubMedCrossRef Stender MT, Larsen AC, Sall M, Thorlacius-Ussing O. D-Dimer predicts prognosis and non-resectability in patients with pancreatic cancer: a prospective cohort study. Blood Coagul Fibrinolysis. 2016;27(5):597–601.PubMedCrossRef
16.
go back to reference Zhang LP, Ren H, Du YX, Zheng XH, Zhang ZM, Wang CF. Combination of preoperative fibrinogen and D-dimer as a prognostic indicator in pancreatic ductal adenocarcinoma patients undergoing R0 resection. World J Gastrointest Surg. 2021;13(3):279–302.PubMedPubMedCentralCrossRef Zhang LP, Ren H, Du YX, Zheng XH, Zhang ZM, Wang CF. Combination of preoperative fibrinogen and D-dimer as a prognostic indicator in pancreatic ductal adenocarcinoma patients undergoing R0 resection. World J Gastrointest Surg. 2021;13(3):279–302.PubMedPubMedCentralCrossRef
17.
go back to reference Schulick AC, Moore HB, Schulick RD, Del Chiaro M. Thrombelastography as a Prognostic Tool in Adenocarcinoma of the pancreas. Ann Surg. 2020;272(6):e288–9.PubMedCrossRef Schulick AC, Moore HB, Schulick RD, Del Chiaro M. Thrombelastography as a Prognostic Tool in Adenocarcinoma of the pancreas. Ann Surg. 2020;272(6):e288–9.PubMedCrossRef
18.
go back to reference Moore HB, Paniccia A, Lawson PJ, et al. Utility of viscoelastic assays beyond coagulation: can Preoperative Thrombelastography Indices Predict Tumor Histology, nodal disease, and resectability in patients undergoing pancreatectomy? J Am Coll Surg. 2018;227(1):55–62.PubMedPubMedCentralCrossRef Moore HB, Paniccia A, Lawson PJ, et al. Utility of viscoelastic assays beyond coagulation: can Preoperative Thrombelastography Indices Predict Tumor Histology, nodal disease, and resectability in patients undergoing pancreatectomy? J Am Coll Surg. 2018;227(1):55–62.PubMedPubMedCentralCrossRef
19.
go back to reference Wu M, Li X, Zhang T, Liu Z, Zhao Y. Identification of a nine-gene signature and establishment of a Prognostic Nomogram Predicting overall survival of pancreatic Cancer. Front Oncol. 2019;9:996.PubMedPubMedCentralCrossRef Wu M, Li X, Zhang T, Liu Z, Zhao Y. Identification of a nine-gene signature and establishment of a Prognostic Nomogram Predicting overall survival of pancreatic Cancer. Front Oncol. 2019;9:996.PubMedPubMedCentralCrossRef
20.
go back to reference Jurk K, Kehrel BE. Platelets: physiology and biochemistry. Semin Thromb Hemost. 2005;31(4):381–92.PubMedCrossRef Jurk K, Kehrel BE. Platelets: physiology and biochemistry. Semin Thromb Hemost. 2005;31(4):381–92.PubMedCrossRef
21.
go back to reference Jackson SP. Arterial thrombosis–insidious, unpredictable and deadly. Nat Med. 2011;17(11):1423–36.PubMedCrossRef Jackson SP. Arterial thrombosis–insidious, unpredictable and deadly. Nat Med. 2011;17(11):1423–36.PubMedCrossRef
22.
go back to reference Kopp HG, Placke T, Salih HR. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Cancer Res. 2009;69(19):7775–83.PubMedCrossRef Kopp HG, Placke T, Salih HR. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Cancer Res. 2009;69(19):7775–83.PubMedCrossRef
23.
go back to reference Rachidi S, Metelli A, Riesenberg B et al. Platelets subvert T cell immunity against cancer via GARP-TGFbeta axis. Sci Immunol. 2017;2(11). Rachidi S, Metelli A, Riesenberg B et al. Platelets subvert T cell immunity against cancer via GARP-TGFbeta axis. Sci Immunol. 2017;2(11).
24.
go back to reference Ma L, Li W, Liu N, Ding Z, Cai J, Zhang Y. Prothrombin time (PT) and CEA as prognostic predictive biomarkers for postoperative recurrence after curative resection in patients with stage I-III colorectal cancer: a retrospective cohort study. Updates Surg. 2022;74(3):999–1009.PubMedCrossRef Ma L, Li W, Liu N, Ding Z, Cai J, Zhang Y. Prothrombin time (PT) and CEA as prognostic predictive biomarkers for postoperative recurrence after curative resection in patients with stage I-III colorectal cancer: a retrospective cohort study. Updates Surg. 2022;74(3):999–1009.PubMedCrossRef
25.
go back to reference Wang HS, Ge XX, Li QP, Nie JJ, Miao L. Clinical significance of Prothrombin Time in Cholangiocarcinoma patients with Surgeries. Can J Gastroenterol Hepatol. 2019;2019:3413969.PubMedPubMedCentralCrossRef Wang HS, Ge XX, Li QP, Nie JJ, Miao L. Clinical significance of Prothrombin Time in Cholangiocarcinoma patients with Surgeries. Can J Gastroenterol Hepatol. 2019;2019:3413969.PubMedPubMedCentralCrossRef
26.
go back to reference Huang WJ, Wang GY, Liu ZY, et al. Preoperative PDW levels predict pulmonary metastasis in patients with hepatocellular carcinoma. BMC Cancer. 2022;22(1):683.PubMedPubMedCentralCrossRef Huang WJ, Wang GY, Liu ZY, et al. Preoperative PDW levels predict pulmonary metastasis in patients with hepatocellular carcinoma. BMC Cancer. 2022;22(1):683.PubMedPubMedCentralCrossRef
27.
go back to reference Liu C, Zhang H, Qi Q, Zhang B, Yue D, Wang C. The preoperative platelet distribution width: a predictive factor of the prognosis in patients with non-small cell lung cancer. Thorac Cancer. 2020;11(4):918–27.PubMedPubMedCentralCrossRef Liu C, Zhang H, Qi Q, Zhang B, Yue D, Wang C. The preoperative platelet distribution width: a predictive factor of the prognosis in patients with non-small cell lung cancer. Thorac Cancer. 2020;11(4):918–27.PubMedPubMedCentralCrossRef
28.
go back to reference Sakin A, Sahin S, Sakin A, et al. Mean platelet volume and platelet distribution width correlates with prognosis of early colon cancer. J BUON. 2020;25(1):227–39.PubMed Sakin A, Sahin S, Sakin A, et al. Mean platelet volume and platelet distribution width correlates with prognosis of early colon cancer. J BUON. 2020;25(1):227–39.PubMed
29.
go back to reference Gorantla B, Asuthkar S, Rao JS, Patel J, Gondi CS. Suppression of the uPAR-uPA system retards angiogenesis, invasion, and in vivo tumor development in pancreatic cancer cells. Mol Cancer Res. 2011;9(4):377–89.PubMedCrossRef Gorantla B, Asuthkar S, Rao JS, Patel J, Gondi CS. Suppression of the uPAR-uPA system retards angiogenesis, invasion, and in vivo tumor development in pancreatic cancer cells. Mol Cancer Res. 2011;9(4):377–89.PubMedCrossRef
30.
go back to reference Kwaan HC, McMahon B. The role of plasminogen-plasmin system in cancer. Cancer Treat Res. 2009;148:43–66.PubMedCrossRef Kwaan HC, McMahon B. The role of plasminogen-plasmin system in cancer. Cancer Treat Res. 2009;148:43–66.PubMedCrossRef
32.
go back to reference Baluka D, Urbanek T, Lekstan A, et al. The role of the tissue plasminogen activator as a prognostic and differentiation factor in patients with pancreatic cancer and chronic pancreatitis. J Physiol Pharmacol. 2016;67(1):93–101.PubMed Baluka D, Urbanek T, Lekstan A, et al. The role of the tissue plasminogen activator as a prognostic and differentiation factor in patients with pancreatic cancer and chronic pancreatitis. J Physiol Pharmacol. 2016;67(1):93–101.PubMed
33.
go back to reference Gibbs JF, Schlieman M, Singh P, et al A pilot study of urokinase-type plasminogen activator (uPA) overexpression in the brush cytology of patients, Iasonos A, Schrag D, Raj GV, Panageas KS et al. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370.with malignant pancreatic or biliary strictures. HPB Surg. 2009;2009:805971. Gibbs JF, Schlieman M, Singh P, et al A pilot study of urokinase-type plasminogen activator (uPA) overexpression in the brush cytology of patients, Iasonos A, Schrag D, Raj GV, Panageas KS et al. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370.with malignant pancreatic or biliary strictures. HPB Surg. 2009;2009:805971.
34.
go back to reference Li J, Wang Y, Li J, Che G. Prognostic value of pretreatment D-Dimer level in small-cell lung Cancer: a Meta-analysis. Technol Cancer Res Treat. 2021;20:1533033821989822.PubMedPubMedCentral Li J, Wang Y, Li J, Che G. Prognostic value of pretreatment D-Dimer level in small-cell lung Cancer: a Meta-analysis. Technol Cancer Res Treat. 2021;20:1533033821989822.PubMedPubMedCentral
35.
go back to reference Liu P, Wang Y, Tong L, et al. Elevated preoperative plasma D-dimer level is a useful predictor of chemoresistance and poor disease outcome for serous ovarian cancer patients. Cancer Chemother Pharmacol. 2015;76(6):1163–71.PubMedCrossRef Liu P, Wang Y, Tong L, et al. Elevated preoperative plasma D-dimer level is a useful predictor of chemoresistance and poor disease outcome for serous ovarian cancer patients. Cancer Chemother Pharmacol. 2015;76(6):1163–71.PubMedCrossRef
36.
go back to reference Cao J, Fu Z, Gao L, et al. Evaluation of serum D-dimer, fibrinogen, and CA19-9 for postoperative monitoring and survival prediction in resectable pancreatic carcinoma. World J Surg Oncol. 2017;15(1):48.PubMedPubMedCentralCrossRef Cao J, Fu Z, Gao L, et al. Evaluation of serum D-dimer, fibrinogen, and CA19-9 for postoperative monitoring and survival prediction in resectable pancreatic carcinoma. World J Surg Oncol. 2017;15(1):48.PubMedPubMedCentralCrossRef
38.
go back to reference Kupcinskiene K, Trepenaitis D, Petereit R, et al. Monitoring of hypercoagulability by Thromboelastography in bariatric surgery. Med Sci Monit. 2017;23:1819–26.PubMedPubMedCentralCrossRef Kupcinskiene K, Trepenaitis D, Petereit R, et al. Monitoring of hypercoagulability by Thromboelastography in bariatric surgery. Med Sci Monit. 2017;23:1819–26.PubMedPubMedCentralCrossRef
39.
go back to reference Oo J, Allen M, Loveday BPT, et al. Coagulation in liver surgery: an observational haemostatic profile and thromboelastography study. ANZ J Surg. 2020;90(6):1112–8.PubMedCrossRef Oo J, Allen M, Loveday BPT, et al. Coagulation in liver surgery: an observational haemostatic profile and thromboelastography study. ANZ J Surg. 2020;90(6):1112–8.PubMedCrossRef
40.
go back to reference Liu J, Wang N, Chen Y, Lu R, Ye X. Thrombelastography coagulation index may be a predictor of venous thromboembolism in gynecological oncology patients. J Obstet Gynaecol Res. 2017;43(1):202–10.PubMedCrossRef Liu J, Wang N, Chen Y, Lu R, Ye X. Thrombelastography coagulation index may be a predictor of venous thromboembolism in gynecological oncology patients. J Obstet Gynaecol Res. 2017;43(1):202–10.PubMedCrossRef
41.
go back to reference Wang Z, Li J, Cao Q, Wang L, Shan F, Zhang H. Comparison between Thromboelastography and Conventional Coagulation tests in Surgical patients with localized prostate Cancer. Clin Appl Thromb Hemost. 2018;24(5):755–63.PubMedCrossRef Wang Z, Li J, Cao Q, Wang L, Shan F, Zhang H. Comparison between Thromboelastography and Conventional Coagulation tests in Surgical patients with localized prostate Cancer. Clin Appl Thromb Hemost. 2018;24(5):755–63.PubMedCrossRef
42.
go back to reference Wang X, Shi A, Huang J, Chen Y, Xue W, Zhang J. Assessment of hypercoagulability using thromboelastography predicts advanced status in renal cell carcinoma. J Clin Lab Anal. 2020;34(1):e23017.PubMedCrossRef Wang X, Shi A, Huang J, Chen Y, Xue W, Zhang J. Assessment of hypercoagulability using thromboelastography predicts advanced status in renal cell carcinoma. J Clin Lab Anal. 2020;34(1):e23017.PubMedCrossRef
43.
44.
go back to reference Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–70.PubMedCrossRef Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–70.PubMedCrossRef
45.
go back to reference Wang Y, Du L, Yang X, et al. A nomogram combining long non-coding RNA expression profiles and clinical factors predicts survival in patients with bladder cancer. Aging. 2020;12(3):2857–79.PubMedPubMedCentralCrossRef Wang Y, Du L, Yang X, et al. A nomogram combining long non-coding RNA expression profiles and clinical factors predicts survival in patients with bladder cancer. Aging. 2020;12(3):2857–79.PubMedPubMedCentralCrossRef
Metadata
Title
Establishment and validation of a nomogram based on coagulation parameters to predict the prognosis of pancreatic cancer
Authors
Peng Yunpeng
Yin Lingdi
Zhu Xiaole
Huang Dongya
Hu Le
Lu Zipeng
Zhang Kai
Hou Chaoqun
Miao Yi
Guo Feng
Li Qiang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-10908-0

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine